TPM3 and cancer: According to the prevalence of NTRK gene fusions, physiological expression of the TRK protein, and the popularity of NGS tests (30% as cut‐off threshold), classifying cancers into three types and performing a NTRK gene fusion test, as stated in Figure 2, is recommended